Frequency of inappropriate therapy in patients implanted with dual-versus single-chamber ICD devices in the ICD arm of MADIT-CRT

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 6, 2013, Pages 672-679

  Ruwald, Anne Christine H ^a   Sood, Nitesh ^c   Ruwald, Martin H ^a,b   Jons, Christian ^b   Clyne, Christopher A ^c   McNitt, Scott ^a   Wang, Paul ^d   Zareba, Wojciech ^a   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c HARTFORD HOSPITAL   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

complications; dual chamber; heart failure; implantable cardioverter defibrillator; inappropriate therapy; MADIT CRT; single chamber

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOUBLE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; PRIORITY JOURNAL; SINGLE CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; TACHYCARDIA;

AGED; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84878592320     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12099     Document Type: Article

References (26)

1. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G,: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New Engl J Med 1999; 341: 1882-1890.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B,: Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1302.
3. Kuck KH, Cappato R, Siebels J, Ruppel R,: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M,: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
6. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997; 337: 1576-1583.
7. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
8. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J,: Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-594.
9. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ,: Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365.
10. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ,: Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57: 556-562.
11. Theuns DA, Klootwijk AP, Goedhart DM, Jordaens LJ,: Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol 2004; 44: 2362-2367.
12. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, Schmitt C,: Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001; 12: 134-142.
13. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M,: Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: The detect supraventricular tachycardia study. Circulation 2006; 113: 2871-2879.
14. Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, DeSanto T, Grammatico A, Santini M,: Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial. Europace 2009; 11: 587-593.
15. Dorian P, Philippon F, Thibault B, Kimber S, Sterns L, Greene M, Newman D, Gelaznikas R, Barr A,: Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 2004; 1: 540-547.
16. Theuns DA, Rivero-Ayerza M, Boersma E, Jordaens L,: Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. Int J Cardiol 2008; 125: 352-357.
17. Dewland TA, Pellegrini CN, Wang Y, Marcus GM, Keung E, Varosy PD,: Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol 2011; 58: 1007-1013.
18. Kolb C, Deisenhofer I, Schmieder S, Barthel P, Zrenner B, Karch MR, Schmitt C,: Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators. Pacing Clinical Electrophysiol 2006; 29: 946-952.
19. Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A,: Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: Results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. Europace 2008; 10: 528-535.
20. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW,: Complications leading to surgical revision in implantable cardioverter defibrillator patients: Comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace 2009; 11: 297-302.
21. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W,: Cardiac-resynchronization therapy for the prevention of heart-failure events. New Engl J Med 2009; 361: 1329-1338.
22. Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, Foster E, Greenberg HM, Hall WJ, Higgins SL, Klein H, Pfeffer M, Wilber D, Zareba W,: Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): Design and clinical protocol. Ann Noninvasive Electrocardiol 2005; 10 (Suppl 4): 34-43.
23. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ,: Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 2005; 111: 2898-2905.
24. Brugada J, Mont L, Figueiredo M, Valentino M, Matas M, Navarro-Lopez F,: Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol 1998; 9: 261-268.
25. Webber MR, Stiles MK,: Recommendations for the programming of implantable cardioverter-defibrillators in New Zealand. Heart Lung Circ 2012; 21: 765-777.
26. Lee MA, Corbisiero R, Nabert DR, Coman JA, Giudici MC, Tomassoni GF, Turk KT, Breiter DJ, Zhang Y,: Clinical results of an advanced SVT detection enhancement algorithm. Pacing Clin Electrophysiol 2005; 28: 1032-1040.